Larvol Delta - Aprea-Therapeuticsannounced-that-two-abstracts-on-its-clinical-programs-APR1051-amd-ATRN119-have-been-accepted-for-poster-presentation-at-the-EORTCNCIAACR-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics

ATRN-119 - Aprea

APR-1051 - Aprea

https://www.globenewswire.com/news-release/2025/10/14/3166130/0/en/Aprea-Therapeutics-Announces-Presentations-at-EORTC-NCI-AACR-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

Oct 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next